Bioresorbable Vascular Scaffold Market - Global Forecast to 2026, Product Type (Synthetic, Biological), by Material (Metal based BVS, Polymer Based BVS), by application (Coronary Artery Stents, Peripheral Artery Stents, Others), by End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • Published On : Jan 2019 |
  • Pages : 158 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Bioresorbable Vascular Scaffold Market

Bioresorbable vascular stents expand the blood vessel to prevent a blockage, which are disintegrated in human body without any external intervention. It prevents inflammation leading to stent restenosis and thrombosis and eliminates the need for post-treatment involvements. Bioresorbable stents are superior over 1st and 2nd generation stents as Bioresorbable stents cut the need for dual antiplatelet therapies.

The global bioresorbable vascular scaffold market size was valued at US$ 147.0 million in 2017, and is expected to exhibit a CAGR of 12.5% over the forecast period (2018 – 2026).

Figure 1. Global Bioresorbable Vascular Scaffold Market Value (US$ Mn), by Region, 2017

Bioresorbable Vascular Scaffold  | Coherent Market Insights

                                                                    Source: Coherent Market Insights Analysis (2018)

Increasing prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel growth of the bioresorbable vascular scaffold market

Bioresorbable vascular scaffold is used in treatment of blockage of coronary and peripheral artery, which is related to coronary heart disease, ischemic heart disease, and other cardiovascular diseases. High prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to propel demand for bioresorbable vascular scaffold, which in turn will drive the market growth. According to World Health Organization (WHO), 2015, cardiovascular diseases is the first leading cause of morbidity and mortality worldwide, with around 17.7 million representing 31% of all global deaths in 2015, out of these deaths, an estimated 6.7 million were due to stroke and 7.4 million were due to coronary heart disease.

Similarly, according to American Heart Association in 2018, 92.1 million American adults were suffering with some form of cardiovascular disease or the after-effects of stroke. Nearly 836,546 deaths in the U.S. were due to cardiovascular disease, which is about 1 of every 3 deaths. Direct and indirect costs in the treatment of cardiovascular diseases and stroke were estimated to amount to US$ 329.7 billion in 2018, which includes both health expenditures and lost productivity, in the U.S.

Furthermore, introduction of novel bioresorbable vascular scaffold, which help patients with cardiovascular diseases, is propelling growth of the bioresorbable vascular scaffolds market over the forecast period. For instance, in July 2016, Abbott received approval from the US Food and Drug Administration for Absorb GT1 bioresorbable vascular scaffold (BVS). The product fully resorbs over time and improves coronary luminal diameter in patients with ischemic heart disease due to de novo native coronary artery lesions.

However, complications such as damage to central veins, pulmonary complications, cardiac complications, device dysfunction, and catheter-related bloodstream infection are expected to limit adoption of bioresorbable vascular scaffold, thereby hindering the market growth.

Figure 2. Global Bioresorbable Vascular Scaffold Market Share (%), by Material, 2018 and 2026

Bioresorbable Vascular Scaffold  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Increasing adoption of bioresorbable vascular scaffolds in North America is expected to boost the market growth

North America is expected to be held dominant position in the global bioresorbable vascular scaffold market, owing to rapid growth in geriatric population, rising incidences of cardiac ailments, coronary & peripheral artery diseases, and increasing number of obese people in the region. According to World Population Prospects, the number of persons aged 80 or over is projected to triple by 2050, from 137 million in 2017, to 425 million in 2050 in the U.S., while this age bracket is expected to more than double globally, rising from 962 million in 2017 to 2.1 billion in 2050.

Moreover, key players in the market are focused on receiving regulatory approvals for novel products to reduce the burden of blood stream infections associated with bioresorbable vascular scaffolds. For instance, in May, 2018, Pursuit Vascular, Inc., received U.S. FDA clearance for broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with bioresorbable vascular scaffolds.

Key Players

Major players operating in the global bioresorbable vascular scaffold market include Abbott, Cook Medical, Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc., Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, C. R. Bard, Inc., and Theragenics Corporation.

Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.

Market Dynamics

Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.

Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.

However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Bioresorbable Vascular Scaffold Market, By Product Type:
    • Synthetic
    • Biological
  • Global Bioresorbable Vascular Scaffold Market, By Material Type:
    • Metal based BVS
    • Polymer based BVS
  • Global Bioresorbable Vascular Scaffold Market, By Application
    • Coronary Artery Stents
    • Peripheral Artery Stents
    • Others
  • Global Bioresorbable Vascular Scaffold Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Centers
    • Others
  • Global Bioresorbable Vascular Scaffold Market, By Geography:
    • North America
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Synthetic
        • Biological
      • By Material:
        • Metal based BVS
        • Polymer based BVS
      • By Application:
        • Coronary Artery Stents
        • Peripheral Artery Stents
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Centers
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Cook Medical
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • Medtronic Plc
    • Stentys SA
    • MAQUET Holding B.V. & Co. KG (Getinge AB)
    • W.L. Gore & Associates
    • C. R. Bard, Inc.,
    • Theragenics Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Material Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Impact Analysis
    • Key Highlights
    • PEST Analysis
    • Pricing Analysis
    • Brand Analysis
    • Regulatory Framework
    • PORTER’s Analysis
    • Mergers and Acquisitions
    • Technological Advancements
    • Epidemiology
  4. Global Bioresorbable Vascular Scaffold  Market, By Product Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017– 2026
      • Segment Trends
    • Synthetic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Biological
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  5. Global Bioresorbable Vascular Scaffold  Market, By Material Type, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017– 2026
      • Segment Trends
    • Metal based BVS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Polymer based BVS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  6. Global Bioresorbable Vascular Scaffold  Market, By Application, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017– 2026
      • Segment Trends
    • Coronary Artery Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Peripheral Artery Stent
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  7. Global Bioresorbable Vascular Scaffold  Market, By End User, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017– 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Cardiac center
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  8. Global Bioresorbable Vascular Scaffold  Market, By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Material, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application , 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By End User, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • AngioDynamics, Inc.*
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C. R. Bard, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teleflex Incorporated
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc
        •  Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vygon Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Medical Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Argon Medical Devices, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ICU Medical, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Theragenics Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 22 market data tables and 26 figures on "Bioresorbable Vascular Scaffold Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.